Not Tagged
Astrazeneca
[]
 while preliminary in both cases, should trends hold, i still don t see how they compete with azn (via keymed) which had 100% orr at likely rp2d (asco-gi-23), and also uses mmae. 
Ph.D Chemist. Views are my own.
All Tweets are not endorsements or recommendations